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Abstract. Tuberculosis is an important cause of morbidity and mortality world-
wide. We report the case of a 52-year-old man who presented with a two month 
history of sore throat without other general or respiratory symptoms. Oral ex-
amination revealed ulcerative and granulomatous lesions on the soft palate and 
tonsils. Histological examination of the lesions showed granulomatous tissue with 
caseaous necrosis consistent with tuberculosis. A chest x-ray and computed to-
mography of the chest showed miliary tuberculosis of both lungs. The oral lesions 
improved with antituberculous medication by one month. Tuberculosis should be 
considered in the differential diagnosis of oral lesions which do not respond to 
appropriate antibiotic therapy. Pulmonary tuberculosis should also be considered 
in patients with oral tuberculosis even if they do not have respiratory symptoms. 
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cobacterium tuberculosis (Singhaniya et al, 
2011). The prevalence of tuberculosis 
has decreased over the past few decades 
(Smolka et al, 2008). However, the inci-
dence of TB has increased recently due 
to greater numbers of immunodeficient 
patients and multidrug-resistant strains 
(Sutbeyaz et al, 2000; Frieden et al, 2003; 
Kakisi et al, 2010).
One-third of people world-wide are 
infected with TB (Golden and Vikram, 
2005; Kakisi et al, 2010). Two million 
people die yearly due to tuberculosis 
(Frieden et al, 2003). Early detection and 
proper treatment of TB are important. 
TB commonly presents with pulmonary 
INTRODUCTION
Tuberculosis (TB) is an infectious 
disease caused by bacteria such as My-
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manifestations but may infest the head 
and neck with or without pulmonary 
TB. Cervical lymphadenitis is the most 
commonly involved site of the head and 
neck (Golden and Vikram, 2005), and 
oropharyngeal tuberculosis is rare (Kakisi 
et al, 2010). We report a rare case of oro-
pharyngeal tuberculosis associated with 
asymptomatic pulmonary TB.
CASE REPORT
A 52-year-old man was referred from 
a private clinic to the Otolaryngology 
Department, Yongin Severance Hospital 
with a two month of history of hoarseness, 
odynophagia and sore throat. He had no 
cough, sputum production, hemoptysis, 
or other respiratory symptoms. He did not 
have fever, weight loss, night sweats, or 
other generalized symptoms. He denied 
a history of other medical problems. He 
had taken medicine for one month to treat 
suspected tonsillitis without improve-
ment in his symptoms.
Oral examination revealed diffuse 
ulcerative and granulomatous lesions 
on both the soft palate and tonsillar area 
(Fig 1). He had no palpable lymph nodes 
in the neck.
Blood chemistry results were normal. 
His erythrocyte sedimentation rate was el-
evated at 27 mm/hr (0-20 mm/hr ) and his 
C-reactive protein was elevated at 2.1 mg/
dl (0.0-0.5 mg/dl). A biopsy of a lesion was 
performed which showed chronic granu-
lomatous inflammation with caseaous 
necrosis consistent with tuberculosis (Fig 
2A). Ziehl-Neelsen staining for acid-fast 
bacilli was positive (Fig 2B). A polymerase 
chain reaction test for Mycobacterium tuber-
culosis was positive. Further examinations 
of the chest were performed. A chest x-ray 
(Fig 3) and computed tomography of the 
chest (Fig 4) showed miliary tuberculosis 
Fig 1–Diffuse ulcerative and granulomatous 
lesions of the soft palate and tonsils.
of both lungs and a 4 cm cavitary lesion 
with patchy consolidations in the right 
upper lung. Sputum smears and cultures 
were positive for acid-fast bacilli. His HIV 
test was negative.
He was given the diagnosis of oropha-
ryngeal TB with concomitant pulmonary 
TB. He was treated with isoniazid 300 mg, 
rifampin 600 mg, pyrazinamide 1,250 mg, 
pyridoxine 100 mg, and ethambutol 800 
mg daily. His oral symptoms improved 
with medication by one month.
DISCUSSION
Pulmonary TB is the most common 
site of TB; a person usually contacts TB 
by inhalation of the infective organism. 
Extrapulmonary TB, such as tuberculous 
lymphadenitis and pleuritis, are not un-
common and account for approximately 
10%-15% of all TB cases (Smolka et al, 2008). 
However, oral and oropharyngeal tuber-
culosis are rare, accounting for 0.05%-5% 
of all TB cases (Singhaniya et al, 2011). 
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Fig 2–A. Granuloma with a multiple lymphocytes and caseating necrosis and multinucleated Lang-
erhans giant cells. B. A Ziehl-Neelsen stain showed acid-fast bacilli (arrow).
Fig 3–Miliary tuberculosis of both lungs. A 
cavitary lesion and patchy consolidations 
are seen in the right upper lung.
Concurrent pulmonary TB is found in 
about 50% of patients with oral TB (Kakisi 
et al, 2010). However, oral TB is not com-
mon in patients with pulmonary TB, 
despite the infective organism passing 
through the oral cavity in pulmonary TB 
patients (Singhaniya et al, 2011). This is 
because the intact oral mucosa acts as a 
natural barrier and salivary enzymes also 
function as a defense mechanism (Pekiner 
et al, 2006). Hematogenous and lymphatic 
spread are generally suggested as the 
route of spread to oral and oropharyngeal 
areas (Sutbeyaz et al, 2000; Singhaniya et 
al, 2011). However, direct infection is also 
possible in patients with oral mucosal 
defects (Singhaniya et al, 2011).
Oral TB has several presentations 
with ulceration being the most com-
mon (55%), followed by swelling (24%) 
and discharge (10%) (Kakisi et al, 2010). 
Symptoms of oral TB can be nonspecific. 
If generalized symptoms, such as weight 
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loss, persistent fever, malaise, cachexia 
and night sweats, are not present, it is 
challenging to diagnose TB without a 
confirmative study. However, general 
symptoms of TB are seen in only 37% of 
cases (Kakisi et al, 2010). Diagnostic delay 
may be associated with greater morbidity, 
mortality and transmission. TB should 
be considered in oral lesion cases that do 
not respond to treatment. Concomitant 
pulmonary TB should also be considered 
in all cases of oral TB. A delay in TB di-
agnosis is common. Sreeramareddy et al 
(2009) found it took an average of two 
months to diagnose pulmonary TB.
 Microscopic examination for acid-
fast bacilli using Ziehl-Neelsen staining 
and mycobacterial cultures of respiratory 
samples are generally used to diagnose 
pulmonary TB (Golden and Vikram, 2005). 
However, biopsy is usually needed to 
diagnose oropharyngeal TB because con-
ventional acid-fast bacilli staining and TB 
cultures have a low sensitivity for detect-
ing oral TB lesions: 52% by AFB stain and 
50% by culture (Kakisi et al, 2010; Shinga-
dia, 2012). Pathological characteristics of 
TB, such as caseous necrosis, epithelioid 
structures, such as Giant or Langhans cells, 
are helpful for diagnosis of oral TB (Kakisi 
et al, 2010). Polymerase chain reaction 
(PCR) also has a good sensitivity (89%-
100%) for detecting mycobacteria (Smolka 
et al, 2008; Kakisi et al, 2010; Shingadia, 
2012). Real-time PCR has the advantage 
of identifying rifampicin resistance and 
is helpful to choosing the medication regi-
men. TB strains with rifampin resistance 
also often have isoniazid resistance (Shin-
gadia, 2012). However, the PCR may fail to 
detect mycobacterium (Kakisi et al, 2010).
In the patients with oral cavity TB, 
evaluation of the lungs should be per-
formed. A chest x-ray is commonly used 
to detect pulmonary TB; radiographic 
findings, such as upper-lobe infiltrates, 
cavitary infiltrates, and hilar or paratra-
cheal adenopathy, suggest pulmonary TB 
(Frieden et al, 2003). However, chest CT 
may be more useful for detecting early TB 
lesions and cavitary lesions (Prasad and 
Bhardwaj, 2012; Shingadia, 2012).
Hematologic malignancies, such as 
lymphoma, as well as sarcoidosis, syphilis 
and Wegner’s granulomatosis, should also 
be considered in the differential diagnosis 
of chronic ulcerative oral disease (Frieden 
et al, 2003; Smolka et al, 2008). Evaluation 
for immunocompromised states, such as 
HIV infection, is also necessary, especially 
in patients with extrapulmonary TB, since 
more than 50% of patients with concur-
rent HIV infection and TB present with 
extrapulmonary involvement (Golden 
and Vikram, 2005).
Anti-tuberculous medication for 
six to nine months is recommended as 
Fig 4–Miliary nodules with a cavitary lesion in 
right upper lung.
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treatment for extrapulmonary TB. Usu-
ally, two months of isoniazid, rifampin, 
pyrazinamide, and ethambutol, followed 
by four to seven months of isoniazid 
and rifampin, is effective except in cases 
suspected to be resistant to the first-line 
drugs (Golden and Vikram, 2005; Kakisi 
et al, 2010). Oral TB lesions and symptoms 
improve with TB medication within two 
to eight weeks (Frieden et al, 2003; Smolka 
et al, 2008; Singhaniya et al, 2011).
In conclusion, oropharyngeal tu-
berculosis should be considered when 
chronic oral lesions do not respond to 
routine medical therapy. The possibility of 
concomitant pulmonary TB should also be 
considered in patients with oral TB, even 
if the patient does not have generalized 
or respiratory symptoms.
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